Immediate Impact
3 from Science/Nature 61 standout
Citing Papers
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Shining New Light on Biological Systems: Luminescent Transition Metal Complexes for Bioimaging and Biosensing Applications
2024 Standout
Works of James Nelson being referenced
Generation and characterization of ixekizumab, a humanized monoclonal antibody that neutralizes interleukin-17A
2016
Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis
1997
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| James Nelson | 427 | 126 | 367 | 289 | 21 | 1.1k | |
| G. K. T. Holmes | 474 | 123 | 155 | 325 | 16 | 1.3k | |
| Anna Hayden | 241 | 34 | 323 | 129 | 19 | 1.2k | |
| Michele Serricchio | 587 | 260 | 180 | 136 | 42 | 1.2k | |
| Moris Cadei | 384 | 45 | 222 | 250 | 43 | 1.1k | |
| Melanie Grimm | 133 | 291 | 427 | 44 | 16 | 1.4k | |
| A A Wirz | 931 | 253 | 108 | 577 | 18 | 1.1k | |
| Mustafa Gülşen | 393 | 91 | 88 | 90 | 26 | 1.2k | |
| Mikael Knutsson | 263 | 206 | 83 | 77 | 37 | 1.2k | |
| Elizabeth Redmond | 230 | 42 | 210 | 204 | 14 | 1.0k | |
| Michelle Buresi | 303 | 35 | 47 | 382 | 29 | 859 |
All Works
Login with ORCID to disown or claim papers
Loading papers...